OUTBRAIN INC (OB) Fundamental Analysis & Valuation

NASDAQ:OB • US69002R1032

Current stock price

2.74 USD
-0.07 (-2.49%)
At close:
2.8 USD
+0.06 (+2.19%)
After Hours:

This OB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. OB Profitability Analysis

1.1 Basic Checks

  • In the past year OB has reported negative net income.
  • In the past year OB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: OB reported negative net income in multiple years.
  • Each year in the past 5 years OB had a positive operating cash flow.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.99%, OB is in line with its industry, outperforming 49.30% of the companies in the same industry.
  • With a Return On Equity value of -10.64%, OB perfoms like the industry average, outperforming 46.48% of the companies in the same industry.
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • With a Gross Margin value of 24.31%, OB is not doing good in the industry: 84.51% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of OB has remained more or less at the same level.
  • OB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. OB Health Analysis

2.1 Basic Checks

  • OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, OB has less shares outstanding
  • There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • OB has an Altman-Z score of 0.50. This is a bad value and indicates that OB is not financially healthy and even has some risk of bankruptcy.
  • OB has a Altman-Z score (0.50) which is in line with its industry peers.
  • The Debt to FCF ratio of OB is 15.66, which is on the high side as it means it would take OB, 15.66 years of fcf income to pay off all of its debts.
  • OB has a Debt to FCF ratio (15.66) which is in line with its industry peers.
  • OB has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
  • OB has a worse Debt to Equity ratio (1.32) than 80.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Altman-Z 0.5
ROIC/WACCN/A
WACC8.68%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • OB has a Current Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.13, OB is not doing good in the industry: 76.06% of the companies in the same industry are doing better.
  • OB has a Quick Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
  • OB's Quick ratio of 1.13 is on the low side compared to the rest of the industry. OB is outperformed by 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.00% over the past year.
  • The Revenue has been growing slightly by 4.16% in the past year.
  • OB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.30% yearly.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%

3.2 Future

  • Based on estimates for the next years, OB will show a very strong growth in Earnings Per Share. The EPS will grow by 101.45% on average per year.
  • The Revenue is expected to grow by 7.84% on average over the next years.
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. OB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OB. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 3.30, which indicates a rather cheap valuation of OB.
  • 100.00% of the companies in the same industry are more expensive than OB, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of OB to the average of the S&P500 Index (23.83), we can say OB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.3
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, OB is valued cheaply inside the industry as 94.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA N/A
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OB's earnings are expected to grow with 101.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y355.64%
EPS Next 3Y101.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OB Dividend Analysis

5.1 Amount

  • No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

OB Fundamentals: All Metrics, Ratios and Statistics

OUTBRAIN INC

NASDAQ:OB (6/9/2025, 8:00:02 PM)

After market: 2.8 +0.06 (+2.19%)

2.74

-0.07 (-2.49%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-09
Earnings (Next)08-06
Inst OwnersN/A
Inst Owner Change-14.63%
Ins OwnersN/A
Ins Owner Change0%
Market Cap258.38M
Revenue(TTM)959.27M
Net Income(TTM)-50.51M
Analysts78.46
Price Target5.44 (98.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.21%
Min EPS beat(2)-102.79%
Max EPS beat(2)-17.62%
EPS beat(4)2
Avg EPS beat(4)50.06%
Min EPS beat(4)-102.79%
Max EPS beat(4)284.85%
EPS beat(8)5
Avg EPS beat(8)515.51%
EPS beat(12)7
Avg EPS beat(12)306.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.58%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-5.74%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-5.76%
Revenue beat(12)2
Avg Revenue beat(12)-3.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.42%
PT rev (3m)-35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-180.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)28.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.3
P/S 0.27
P/FCF 6.45
P/OCF 4.38
P/B 0.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.83
Fwd EY30.31%
FCF(TTM)0.42
FCFY15.5%
OCF(TTM)0.63
OCFY22.83%
SpS10.17
BVpS5.03
TBVpS-5.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.31%
FCFM 4.17%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Debt/EBITDA N/A
Cap/Depr 69.03%
Cap/Sales 1.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 0.5
F-Score4
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A
EBIT growth 1Y-360.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3702.14%
EBIT Next 3Y261.82%
EBIT Next 5YN/A
FCF growth 1Y199.3%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y520.46%
OCF growth 3Y6.5%
OCF growth 5Y32.58%

OUTBRAIN INC / OB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OUTBRAIN INC?

ChartMill assigns a fundamental rating of 3 / 10 to OB.


What is the valuation status for OB stock?

ChartMill assigns a valuation rating of 6 / 10 to OUTBRAIN INC (OB). This can be considered as Fairly Valued.


What is the profitability of OB stock?

OUTBRAIN INC (OB) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for OB stock?

The Earnings per Share (EPS) of OUTBRAIN INC (OB) is expected to grow by 977.64% in the next year.